RT Journal Article
SR Electronic
T1 Whole Genome Sequence Association Analysis of Fasting Glucose and Fasting Insulin Levels in Diverse Cohorts from the NHLBI TOPMed Program
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.31.20234310
DO 10.1101/2020.12.31.20234310
A1 Daniel DiCorpo
A1 Sheila M Gaynor
A1 Emily M Russell
A1 Kenneth E Westerman
A1 Laura M Raffield
A1 Timothy D Majarian
A1 Peitao Wu
A1 Chloé Sarnowski
A1 Heather M Highland
A1 Anne Jackson
A1 NHLBI Trans-Omics for Precision Medicine (TOPMed) Consortium
A1 Natalie R Hasbani
A1 Paul S de Vries
A1 Jennifer A Brody
A1 Bertha Hidalgo
A1 Xiuqing Guo
A1 James A Perry
A1 Jeffrey R O’Connell
A1 Samantha Lent
A1 May E Montasser
A1 Brian E Cade
A1 Deepti Jain
A1 Heming Wang
A1 Ricardo D’Oliveira Albanus
A1 Arushi Varshney
A1 Lisa R Yanek
A1 Leslie Lange
A1 Nicholette D Palmer
A1 Marcio Almeida
A1 Juan M Peralta
A1 Stella Aslibekyan
A1 Abigail S Baldridge
A1 Alain G Bertoni
A1 Lawrence F Bielak
A1 Chung-Shiuan Chen
A1 Yii-Der Ida Chen
A1 Won Jung Choi
A1 Mark O Goodarzi
A1 James S Floyd
A1 Marguerite R Irvin
A1 Rita R Kalyani
A1 Tanika N Kelly
A1 Seonwook Lee
A1 Ching-Ti Liu
A1 Douglas Loesch
A1 JoAnn E Manson
A1 James S Pankow
A1 Laura J Rasmussen-Torvik
A1 Alexander P Reiner
A1 Elizabeth Selvin
A1 Jennifer A Smith
A1 Daniel E Weeks
A1 Huichun Xu
A1 Jie Yao
A1 Wei Zhao
A1 Stephen Parker
A1 Alvaro Alonso
A1 Donna K Arnett
A1 John Blangero
A1 Eric Boerwinkle
A1 Adolfo Correa
A1 L. Adrienne Cupples
A1 Joanne E Curran
A1 Ravindranath Duggirala
A1 Jiang He
A1 Susan R Heckbert
A1 Sharon LR Kardia
A1 Ryan W Kim
A1 Charles Kooperberg
A1 Simin Liu
A1 Rasika A Mathias
A1 Stephen T McGarvey
A1 Braxton D Mitchell
A1 Alanna C Morrison
A1 Patricia A Peyser
A1 Bruce M Psaty
A1 Susan Redline
A1 Alan R Shuldiner
A1 Kent D Taylor
A1 Ramachandran S Vasan
A1 Karine A Viaud-Martinez
A1 Jose C Florez
A1 James G Wilson
A1 Robert Sladek
A1 Stephen S Rich
A1 Jerome I Rotter
A1 Xihong Lin
A1 Josée Dupuis
A1 James B Meigs
A1 Jennifer Wessel
A1 Alisa K Manning
YR 2021
UL http://medrxiv.org/content/early/2021/01/04/2020.12.31.20234310.abstract
AB The genetic determinants of fasting glucose (FG) and fasting insulin (FI) have been studied mostly through genome and exome arrays, resulting in over 100 associated variants. We extended this work with a high-coverage whole genome sequencing (WGS) analysis from fifteen cohorts in the NHLBI Trans-Omics for Precision Medicine (TOPMed) program. More than 23,000 non-diabetic individuals from five self-reported race/ethnicities (African, Asian, European, Hispanic and Samoan) were included for each trait. We analyzed 60M variants in race/ethnicity-specific and pooled single variant and rare variant aggregate tests. Twenty-two variants across sixteen gene regions were found significantly associated with FG or FI, eight of which were rare (Minor Allele Frequency, MAF<0.05). Functional annotation from resources including the Diabetes Epigenome Atlas were compiled for each signal (chromatin states, annotation principal components, and others) to elucidate variant-to-function hypotheses. Near the G6PC2 locus we identified a distinct FG signal at rare variant rs2232326 (MAF=0.01) after conditioning on known common variants. Functional annotations show rs2232326 to be disruptive and likely damaging while being weakly transcribed in islets. A pair of FG-associated variants were identified near the SLC30A8 locus. These variants, one of which was rare (MAF=0.001) and Asian race/ethnicity-specific, were shown to be in islet-specific active enhancer regions. Other associated regions include rare variants near ROBO1 and PTPRT, and common variants near MTNR1B, GCK, GCKR, FOXA2, APOB, TCF7L2, and ADCY5. We provide a catalog of nucleotide-resolution genomic variation spanning intergenic and intronic regions down to a minor allele count of 20, creating a foundation for future sequencing-based investigation of glycemic traits.Competing Interest StatementJose FlorezDr. Florez has received a consulting honorarium from Goldfinch Bio. and speaker fees from Novo Nordisk James S. FloydDr. Floyd has consulted for Shionogi Inc Bruce M. PsatyPsaty serves on the Steering Committee of the Yale Open Data Access Project funded by Johnson & Johnson. Stella AslibekyanSA holds equity in 23andMe, Inc. Funding StatementSee Supplementary Tables (SUPPL.TABLE.16.Funding.21DEC2020.xlsx) for funding statements from TOPMed, study, individual and resources.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study participants provided informed consent, and each study's Institutional Review Board [or ethics review committee] provided approval. Details are provided in Supplementary Table (SUPP.TABLE.FG.FI.ParentStudy.Ethics.Statements.xlsx).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe summary results generated during this study are available at the AMP-T2D Portal, http://t2d.hugeamp.org/. http://t2d.hugeamp.org/